A091902 (Soft Tissue Sarcoma) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to see how an experimental drug called nivolumab works in your body and against your cancer.
Soft Tissue Sarcoma (Angiosarcoma)
Who Can Participate in the Study?
Adults ages 18 and older who have angiosarcoma.
What is Involved?
We are enrolling people who have not been treated with a class of anticancer drugs called taxanes.
If you join this study, you will:
- Be randomly assigned (a fair 50/50 chance) to either Group 1 or Group 2
-- Group 1 will get treatment with a chemotherapy drug called paclitaxel and the study drug nivolumab
-- Group 2 will get treatment with paclitaxel alone